Adnkronos "There are new developments and new therapeutic approaches for the management of bleeding" related to platelet disorders. A new bispecific monoclonal antibody is undergoing advanced clinical trials, with many Italian centers participating, which is very promising. We hope the trial will soon offer this new therapeutic option to patients."
Thus stated Paolo Gresele, professor of Internal Medicine at the University of Perugia, speaking in Rome at the 29th National Congress of Siset – the Italian Society for the Study of Hemostasis and Thrombosis.
https://www.youtube.com/watch?v=-_VoeBiXik0
Continue on the app
The news of your city, in real time.
Open in app